Amyloidosis , types , symptoms , diagnosis and diagnostic test

Reading File
Finding Sources
Finding Sources
Searching Images

amyloidosis Congo red staining apple green birefringence histology

Light microscopy image of a lymph node biopsy stained with Congo Red and examined under polarized light. The tissue reveals extracellular, amorphous eosinophilic deposits distributed throughout nodal architecture consistent with amyloid. The deposits assume a dense, granular to plaque-like appearance on routine brightfield, and demonstrate distinctive apple-green birefringence when illuminated with polarized light, confirming the beta-pleated sheet rich configuration of amyloid fibrils. Congo Red positivity with birefringence distinguishes amyloid from other PAS-positive glycoprotein material and helps differentiate from non-amyloid nodal deposits. The beta-pleated sheet conformation accounts for the characteristic staining behavior and optical properties used in diagnosis. Clinically, identification of nodal amyloid supports systemic or localized amyloidosis and prompts workup for light-chain (AL) or serum amyloid A (AA) subtypes, including serum free light chains, immunofixation, and mass spectrometry-based typing. This image is relevant for educational illustrations of amyloid histology, pathophysiology, and diagnostic pathology workflows, including differential diagnosis with glycoprotein-rich PAS-positive deposits that are Congo Red negative. Potential clinical scenarios include workup of lymphadenopathy in patients with chronic inflammatory states, plasma cell dyscrasias, and lymphoproliferative disorders. High quality images like this support interdepartmental communication, teaching, and reproducible reporting of amyloid histology for junior pathologists and medical trainees in pathology education programs.

Light microscopy image of a lymph node biopsy stained with Congo Red and examined under polarized light. The tissue reveals extracellular, amorphous eosinophilic deposits distributed throughout nodal architecture consistent with amyloid. The deposits assume a dense, granular to plaque-like appearance on routine brightfield, and demonstrate distinctive apple-green birefringence when illuminated with polarized light, confirming the beta-pleated sheet rich configuration of amyloid fibrils. Congo Red positivity with birefringence distinguishes amyloid from other PAS-positive glycoprotein material and helps differentiate from non-amyloid nodal deposits. The beta-pleated sheet conformation accounts for the characteristic staining behavior and optical properties used in diagnosis. Clinically, identification of nodal amyloid supports systemic or localized amyloidosis and prompts workup for light-chain (AL) or serum amyloid A (AA) subtypes, including serum free light chains, immunofixation, and mass spectrometry-based typing. This image is relevant for educational illustrations of amyloid histology, pathophysiology, and diagnostic pathology workflows, including differential diagnosis with glycoprotein-rich PAS-positive deposits that are Congo Red negative. Potential clinical scenarios include workup of lymphadenopathy in patients with chronic inflammatory states, plasma cell dyscrasias, and lymphoproliferative disorders. High quality images like this support interdepartmental communication, teaching, and reproducible reporting of amyloid histology for junior pathologists and medical trainees in pathology education programs.

This renal cortical histology specimen demonstrates AL-type amyloidosis with kidney involvement in a patient with multiple myeloma. The left panel shows hematoxylin and eosin–stained tissue with amorphous, eosinophilic extracellular deposits within the glomerular mesangium and extending into the tubulointerstitium, causing mesangial expansion and variable basement membrane thickening. The right panel uses Congo Red staining to highlight the amyloid deposits, which appear salmon-pink on bright-field examination. Under polarized light, the same deposits display the diagnostic apple-green birefringence, a hallmark of Congo Red–positive amyloid. The deposits are diffuse, involving multiple glomeruli and extending into the tubulointerstitium, sometimes outlining capillary walls. In AL amyloidosis associated with plasma cell dyscrasia, the deposited light-chain–derived proteins disrupt normal renal architecture and contribute to proteinuria and progressive renal impairment. Differential considerations include AA (secondary) amyloidosis and other renal amyloidoses, but the combination of a known plasma cell disorder, Congo Red positivity, and apple-green birefringence strongly supports AL-type amyloidosis. This image serves as a valuable teaching reference for renal pathology, nephrology, and hematology-oncology, illustrating classic Congo Red histology, amyloid distribution patterns within glomeruli and interstitium, and the polarizing light signature. Correlates with proteinuria and renal dysfunction in many myeloma patients, guiding targeted therapy and monitoring of clonal plasma cell burden.

This renal cortical histology specimen demonstrates AL-type amyloidosis with kidney involvement in a patient with multiple myeloma. The left panel shows hematoxylin and eosin–stained tissue with amorphous, eosinophilic extracellular deposits within the glomerular mesangium and extending into the tubulointerstitium, causing mesangial expansion and variable basement membrane thickening. The right panel uses Congo Red staining to highlight the amyloid deposits, which appear salmon-pink on bright-field examination. Under polarized light, the same deposits display the diagnostic apple-green birefringence, a hallmark of Congo Red–positive amyloid. The deposits are diffuse, involving multiple glomeruli and extending into the tubulointerstitium, sometimes outlining capillary walls. In AL amyloidosis associated with plasma cell dyscrasia, the deposited light-chain–derived proteins disrupt normal renal architecture and contribute to proteinuria and progressive renal impairment. Differential considerations include AA (secondary) amyloidosis and other renal amyloidoses, but the combination of a known plasma cell disorder, Congo Red positivity, and apple-green birefringence strongly supports AL-type amyloidosis. This image serves as a valuable teaching reference for renal pathology, nephrology, and hematology-oncology, illustrating classic Congo Red histology, amyloid distribution patterns within glomeruli and interstitium, and the polarizing light signature. Correlates with proteinuria and renal dysfunction in many myeloma patients, guiding targeted therapy and monitoring of clonal plasma cell burden.

This histology image depicts human cardiac tissue (myocardium) stained with Congo Red and examined under bright-field microscopy. The image highlights extracellular, eosinophilic amyloid deposits that encircle and encroach upon individual cardiomyocytes (perimyocytic/interstitial deposition). The deposits appear as amorphous, orange to salmon-pink material on Congo Red, consistent with amyloid. When the same tissue is examined under polarized light, Congo Red–positive material exhibits characteristic apple-green birefringence, a pathognomonic feature of amyloidosis. The prevailing pattern is perimyocytic, with amyloid accumulating in the interstitium around myocytes and near small vessels, potentially contributing to myocardial stiffness and diastolic impairment. Histologic architecture shows preserved cellular morphology of myocytes with basophilic nuclei contrasted against the pink-red amyloid matrix. This image is diagnostic for cardiac amyloidosis on biopsy and would typically prompt typing (AL vs ATTR) by immunohistochemistry or mass spectrometry, as well as correlation with serum free light chains or transthyretin testing. Clinically, such infiltration predisposes to restrictive cardiomyopathy, diastolic dysfunction, arrhythmias, and heart failure symptoms. This slide underscores the utility of Congo Red staining in identifying myocardial amyloid deposits and the diagnostic value of polarized light birefringence for definitive confirmation. Useful for teaching, differential diagnosis, and research into infiltrative cardiomyopathies and treatment monitoring.

This histology image depicts human cardiac tissue (myocardium) stained with Congo Red and examined under bright-field microscopy. The image highlights extracellular, eosinophilic amyloid deposits that encircle and encroach upon individual cardiomyocytes (perimyocytic/interstitial deposition). The deposits appear as amorphous, orange to salmon-pink material on Congo Red, consistent with amyloid. When the same tissue is examined under polarized light, Congo Red–positive material exhibits characteristic apple-green birefringence, a pathognomonic feature of amyloidosis. The prevailing pattern is perimyocytic, with amyloid accumulating in the interstitium around myocytes and near small vessels, potentially contributing to myocardial stiffness and diastolic impairment. Histologic architecture shows preserved cellular morphology of myocytes with basophilic nuclei contrasted against the pink-red amyloid matrix. This image is diagnostic for cardiac amyloidosis on biopsy and would typically prompt typing (AL vs ATTR) by immunohistochemistry or mass spectrometry, as well as correlation with serum free light chains or transthyretin testing. Clinically, such infiltration predisposes to restrictive cardiomyopathy, diastolic dysfunction, arrhythmias, and heart failure symptoms. This slide underscores the utility of Congo Red staining in identifying myocardial amyloid deposits and the diagnostic value of polarized light birefringence for definitive confirmation. Useful for teaching, differential diagnosis, and research into infiltrative cardiomyopathies and treatment monitoring.

Imaging modality and technique: histopathology using light microscopy with Congo red staining of cardiac tissue, demonstrating characteristic amyloid deposition in the perimyocytic (pericellular) region of the myocardium. The deposited material appears orange to salmon pink on conventional hematoxylin-eosin–like chromogen, and exhibits classic apple-green birefringence under polarized light, confirming amyloid protein with a beta-pleated sheet configuration. The pattern is typically diffuse to pericellular around individual myocytes, producing a subtle, eosinophilic, amorphous coating that can obscure underlying cardiomyocyte detail. In this specimen, the amyloid is evident as an acellular, amorphous, hyaline-like material hugging muscle fibers, with irregular but cohesive contours and occasional nodular clusters. Congo red positivity combined with birefringence is diagnostic of systemic or cardiac amyloidosis when correlated with clinical data. Typing by immunohistochemistry, immunofluorescence, or mass spectrometry is often required to distinguish AL (light-chain) from ATTR (transthyretin) amyloidosis, which has implications for prognosis and treatment. Clinically, these deposits stiffen the myocardium, contributing to restrictive physiology and heart failure with preserved ejection fraction. The image illustrates foundational histopathologic criteria used in diagnosing cardiac amyloidosis and serves as educational material for pathology residents, cardiology fellows, and medical students studying protein misfolding diseases and Congo red histology. This image supports diagnostic confidence globally.

Imaging modality and technique: histopathology using light microscopy with Congo red staining of cardiac tissue, demonstrating characteristic amyloid deposition in the perimyocytic (pericellular) region of the myocardium. The deposited material appears orange to salmon pink on conventional hematoxylin-eosin–like chromogen, and exhibits classic apple-green birefringence under polarized light, confirming amyloid protein with a beta-pleated sheet configuration. The pattern is typically diffuse to pericellular around individual myocytes, producing a subtle, eosinophilic, amorphous coating that can obscure underlying cardiomyocyte detail. In this specimen, the amyloid is evident as an acellular, amorphous, hyaline-like material hugging muscle fibers, with irregular but cohesive contours and occasional nodular clusters. Congo red positivity combined with birefringence is diagnostic of systemic or cardiac amyloidosis when correlated with clinical data. Typing by immunohistochemistry, immunofluorescence, or mass spectrometry is often required to distinguish AL (light-chain) from ATTR (transthyretin) amyloidosis, which has implications for prognosis and treatment. Clinically, these deposits stiffen the myocardium, contributing to restrictive physiology and heart failure with preserved ejection fraction. The image illustrates foundational histopathologic criteria used in diagnosing cardiac amyloidosis and serves as educational material for pathology residents, cardiology fellows, and medical students studying protein misfolding diseases and Congo red histology. This image supports diagnostic confidence globally.

Reading File
Reading File
Reading File
Searching PubMed

amyloidosis diagnosis treatment

Reading File
Reading File
Reading File
Searching Images

amyloidosis macroglossia clinical signs systemic amyloid

A three-part clinical photograph series demonstrating physical manifestations of systemic amyloidosis. Panel (a) presents an oral view showing macroglossia (enlarged tongue) with characteristic lateral scalloping, where tooth indentations are visible along the tongue's margins. Panel (b) shows the lower extremities of a patient in a supine position, highlighting a flexion contracture of the knee joint and associated muscle stiffness. Panel (c) displays a palmar view of the hand, illustrating sclerodactyly with thickened, stiffened skin on the palm and tapering of the fingers. These multi-system findings—encompassing macroglossia, joint contractures, and skin changes resembling scleroderma—are classic clinical signs of AL amyloidosis (light chain amyloidosis) and related plasma cell dyscrasias. The imagery serves as an educational resource for identifying the diverse musculoskeletal and soft tissue presentations of systemic amyloid deposition.

A three-part clinical photograph series demonstrating physical manifestations of systemic amyloidosis. Panel (a) presents an oral view showing macroglossia (enlarged tongue) with characteristic lateral scalloping, where tooth indentations are visible along the tongue's margins. Panel (b) shows the lower extremities of a patient in a supine position, highlighting a flexion contracture of the knee joint and associated muscle stiffness. Panel (c) displays a palmar view of the hand, illustrating sclerodactyly with thickened, stiffened skin on the palm and tapering of the fingers. These multi-system findings—encompassing macroglossia, joint contractures, and skin changes resembling scleroderma—are classic clinical signs of AL amyloidosis (light chain amyloidosis) and related plasma cell dyscrasias. The imagery serves as an educational resource for identifying the diverse musculoskeletal and soft tissue presentations of systemic amyloid deposition.

A composite of four clinical photographs demonstrating cutaneous and mucosal manifestations of systemic amyloidosis. Panels (a) and (b) show an intraoral and lateral view of the tongue, exhibiting significant macroglossia (enlargement). The tongue surface is irregular and bumpy, with prominent scalloping (crenation) along the lateral margins caused by indentations from the adjacent teeth. Panels (c) and (d) provide close-up views of the lower chest wall, displaying a dense distribution of small, discrete, waxy, papular lesions. These papules are flesh-colored to slightly erythematous and appear well-circumscribed. These findings represent classic diagnostic signs: macroglossia with dental indentations and characteristic papular amyloid skin deposits. The image is highly relevant for medical education concerning restrictive physiology disorders, plasma cell dyscrasias, and the physical examination of multisystemic protein deposition diseases.

A composite of four clinical photographs demonstrating cutaneous and mucosal manifestations of systemic amyloidosis. Panels (a) and (b) show an intraoral and lateral view of the tongue, exhibiting significant macroglossia (enlargement). The tongue surface is irregular and bumpy, with prominent scalloping (crenation) along the lateral margins caused by indentations from the adjacent teeth. Panels (c) and (d) provide close-up views of the lower chest wall, displaying a dense distribution of small, discrete, waxy, papular lesions. These papules are flesh-colored to slightly erythematous and appear well-circumscribed. These findings represent classic diagnostic signs: macroglossia with dental indentations and characteristic papular amyloid skin deposits. The image is highly relevant for medical education concerning restrictive physiology disorders, plasma cell dyscrasias, and the physical examination of multisystemic protein deposition diseases.

Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive content from authoritative textbooks. Let me compile the full answer.

Amyloidosis: Types, Symptoms, Diagnosis and Diagnostic Tests


What is Amyloidosis?

Amyloidosis is a group of diseases characterized by the extracellular deposition of insoluble protein fibrils - called amyloid - in various organs and tissues. All amyloid fibrils share a common structure: an antiparallel β-pleated sheet configuration, which confers their characteristic staining and physical properties. More than 25 different proteins can form these fibrils.
The key pathological features of amyloid include:
  • Binds Congo red dye, producing apple-green birefringence under polarized light (pathognomonic)
  • Stains with thioflavin T (produces fluorescence)
  • Consists of randomly oriented, 8-12 nm nonbranching fibrils on electron microscopy
  • Contains the glycoprotein serum amyloid P component (SAP) in all deposits
  • Deposits cause organ dysfunction mainly by disrupting tissue architecture without triggering inflammation
- Robbins, Cotran & Kumar Pathologic Basis of Disease; Brenner and Rector's The Kidney

Classification / Types of Amyloidosis

Amyloid may be systemic (generalized) or localized to a single organ. The three most common forms are named after the deposited protein:

1. AL Amyloidosis (Primary Amyloidosis)

  • Most common systemic type (~2,000-3,000 new US cases/year)
  • Amyloid protein: immunoglobulin light chains (usually λ > κ) from a clonal plasma cell proliferation
  • Occurs in 5-15% of patients with multiple myeloma; also occurs without overt myeloma (previously called "primary" amyloidosis) - but monoclonal immunoglobulins are detectable in serum or urine in virtually all cases
  • Organs commonly involved: heart, GI tract, kidneys, peripheral nerves, liver, spleen, tongue, skin

2. AA Amyloidosis (Reactive/Secondary Amyloidosis)

  • Amyloid protein: serum amyloid A (SAA), an acute-phase reactant
  • Triggered by chronic inflammation - cytokines (IL-6, IL-1) stimulate hepatic SAA synthesis; long-standing inflammation sustains elevated SAA, eventually leading to fibril deposition
  • Common causes:
    • Rheumatoid arthritis (most common; ~3% of RA patients develop amyloidosis)
    • Ankylosing spondylitis, IBD (Crohn's, ulcerative colitis)
    • Familial Mediterranean Fever (FMF)
    • Chronic infections (TB, bronchiectasis, osteomyelitis)
    • Subcutaneous heroin injection (chronic skin infections)
    • Tumors: renal cell carcinoma, Hodgkin lymphoma
  • Organs commonly involved: kidneys (most prominent), liver, spleen, lymph nodes, adrenals, thyroid

3. ATTR Amyloidosis (Transthyretin Amyloidosis)

  • Amyloid protein: transthyretin (TTR), a transport protein for thyroid hormone and retinol
  • Two subtypes:
    • ATTRwt (wild-type): Caused by age-related misfolding of normal TTR; predominantly in men >70 years old; affects the heart and connective tissues (e.g., carpal tunnel). The second most common systemic amyloidosis and increasing with aging populations
    • ATTRv (variant/hereditary): Autosomal dominant gene mutation in TTR; specific mutations target different organs - some cause familial amyloid polyneuropathy (peripheral/autonomic nerves), others cause familial cardiomyopathy. A V122I variant in TTR is carried by ~4% of African-Americans and causes restrictive cardiomyopathy

4. Hereditary/Familial Amyloidoses (other proteins)

Rare forms involving mutations in genes encoding:
  • Fibrinogen Aα-chain (Afib) - predominantly renal
  • Apolipoprotein A-I or A-II (Apo A-I, A-II)
  • Lysozyme (ALys)
  • Gelsolin (Agel)
  • LECT2 (ALECT2) - more prevalent in Latinos (southwest US), Punjabis, Native Americans, Egyptians

5. Localized Amyloidoses

  • Deposits restricted to a single organ (lung, larynx, skin, bladder, tongue, eye region)
  • Often consist of AL protein from local plasma cell infiltrates

6. Endocrine Amyloidosis

  • Deposits in endocrine tumors: medullary thyroid carcinoma (amyloid is diagnostically helpful), pancreatic islet tumors, pheochromocytoma
  • Also in type 2 diabetes mellitus - islet amyloid polypeptide (IAPP) deposits in pancreatic islets

7. Aβ-Amyloid (Alzheimer's Disease)

  • β-amyloid (Aβ) protein, derived from amyloid precursor protein (APP), forms cerebral plaques and deposits in cerebral blood vessel walls

8. Aβ2m Amyloidosis (Dialysis-Related)

  • β2-microglobulin (a component of MHC class I) deposits in joints and soft tissues of patients on long-term hemodialysis
- Robbins, Cotran & Kumar Pathologic Basis of Disease, Robbins & Kumar Basic Pathology
TypeProteinClinical Setting
ALIg light chainMultiple myeloma, plasma cell dyscrasia
AASerum amyloid AChronic inflammation (RA, FMF, IBD)
ATTRwtWild-type transthyretinElderly men, cardiac
ATTRvMutant transthyretinFamilial neuropathy, cardiomyopathy
β-amyloidAlzheimer disease
Aβ2mβ2-microglobulinLong-term hemodialysis

Clinical Features / Symptoms

Symptoms depend heavily on the organs involved. Amyloid deposits cause dysfunction through mass effect and pressure on cells - without triggering significant inflammation.

Kidney (Most Common and Serious)

  • Proteinuria - often the first sign; progresses to nephrotic syndrome (massive proteinuria, edema, hypoalbuminemia)
  • Progressive renal insufficiency and end-stage renal disease (ESRD)
  • Kidneys may be normal or enlarged early, then shrunken from vascular ischemia

Heart

  • Restrictive cardiomyopathy - myocardial stiffness from perimyocytic amyloid deposition
  • Diastolic heart failure (HFpEF) - exertional dyspnea, peripheral edema
  • Arrhythmias and conduction disturbances
  • "Sparkling" or granular appearance on echocardiography

Peripheral Nervous System

  • Peripheral neuropathy - progressive sensorimotor neuropathy, especially in ATTR amyloidosis
  • Autonomic neuropathy - orthostatic hypotension, impotence, GI dysmotility

Gastrointestinal Tract

  • Macroglossia (enlarged, firm tongue) - almost pathognomonic of AL amyloidosis
  • GI dysmotility, malabsorption, diarrhea
  • GI bleeding (mucosal deposits)
  • Hepatomegaly (liver deposits can be massive)

Skin (particularly AL amyloidosis)

  • Waxy papular lesions on the skin of the eyelids, face, neck, and trunk
  • Easy bruising ("raccoon eyes" - periorbital purpura after minor trauma or Valsalva)
  • Nail dystrophy

Musculoskeletal

  • Carpal tunnel syndrome (common in ATTRwt)
  • Joint stiffness, arthralgias (shoulder-pad sign - amyloid deposits around the shoulder)
  • Muscle weakness (amyloid myopathy)

Other Organs

  • Splenomegaly
  • Adrenal insufficiency (adrenal involvement)
  • Thyroid enlargement
  • Recurrent fevers and serositis (FMF-associated AA amyloidosis)

Clinical Signs (Classic Physical Findings)

Clinical signs of systemic AL amyloidosis: macroglossia with dental indentation, joint contractures, skin changes
Classic AL amyloidosis - macroglossia (enlarged tongue with lateral scalloping from tooth indentation), joint contractures, and sclerodactyly
Macroglossia and waxy papular amyloid skin deposits on the chest
Macroglossia with dental indentations (crenation) and waxy papular skin deposits - hallmarks of systemic AL amyloidosis

Diagnosis

Diagnosis requires tissue biopsy with histological confirmation of amyloid deposition, followed by typing to determine the amyloid precursor protein.

Step 1 - Suspect Amyloidosis (Clinical)

  • Unexplained nephrotic syndrome + cardiomyopathy + neuropathy
  • Plasma cell dyscrasia / myeloma
  • Chronic inflammatory disease with proteinuria
  • Macroglossia + periorbital purpura

Step 2 - Screen for Monoclonal Protein (AL workup)

  • Serum protein electrophoresis (SPEP) - detects M-spike
  • Serum immunofixation electrophoresis (IFE) - more sensitive; identifies monoclonal immunoglobulin
  • 24-hour urine IFE - detects Bence Jones protein (free light chains)
  • Serum free light chain (FLC) assay - measures κ and λ light chains and κ/λ ratio; highly sensitive for AL

Step 3 - Tissue Biopsy (Definitive Diagnosis)

The histological diagnosis of amyloid relies almost entirely on staining characteristics:

Staining Methods

TestFinding
Congo red stainPink/red color under ordinary light → apple-green birefringence under polarized light (pathognomonic)
Thioflavin T/SGreen fluorescence under UV light
H&E stainAmorphous, eosinophilic extracellular deposits
Crystal violet / methyl violetMetachromatic staining (violet→red)
Congo red staining of lymph node - amyloid deposits showing apple-green birefringence under polarized light
Congo red staining under polarized light showing characteristic apple-green birefringence in amyloid deposits (lymph node biopsy)
AL amyloidosis in renal tissue - Congo red staining showing apple-green birefringence in glomerular and interstitial deposits
Renal amyloidosis (AL type) - H&E showing mesangial eosinophilic deposits and Congo red staining with apple-green birefringence (polarized light)
Cardiac amyloidosis - Congo red staining with apple-green birefringence in perimyocytic pattern
Cardiac amyloidosis - amyloid deposits encircling cardiomyocytes (perimyocytic pattern) with Congo red and apple-green birefringence

Biopsy Sites (in order of preference)

  1. Abdominal fat pad aspiration (subcutaneous fat) - safest, least invasive; sensitivity ~70-80%
  2. Rectal biopsy - high yield (~75%), relatively safe
  3. Bone marrow biopsy - often done alongside plasma cell workup
  4. Organ biopsy (kidney, liver, heart) - highest sensitivity but more invasive; needed if fat/rectal biopsy negative and clinical suspicion high
  5. Labial salivary gland biopsy

Step 4 - Typing the Amyloid (Critical - Determines Treatment)

Typing is essential because treatment differs completely by type.

Methods for Typing

TestPurpose
Immunohistochemistry (IHC) on biopsyStains for AL (κ/λ light chains), AA (SAA protein), TTR; limited sensitivity (~65-85%), false positives occur in up to 35%
Laser microdissection + mass spectrometry (LMD-MS)Gold standard for typing; can identify all amyloid types including rare hereditary forms; available in specialized centers
Immunofluorescence (IF)Used in renal biopsies; detects light chain restriction
Genetic testingIdentifies TTR mutations (ATTRv) and other hereditary mutations; recommended in all ATTR cases
Serum free light chain assay + SPEP/IFESupports AL diagnosis

Step 5 - Additional Diagnostic Tests

TestWhat it Detects
Bone marrow biopsy + aspiratePlasma cell percentage; clonality (AL)
Echocardiography"Sparkling" granular myocardium, concentric hypertrophy, diastolic dysfunction - cardiac amyloid
Cardiac MRIDiffuse subendocardial late gadolinium enhancement (LGE) - very characteristic pattern
Serum NT-proBNP / BNPCardiac biomarker; elevated in cardiac involvement; used for staging (Mayo clinic staging)
Serum cardiac troponin (cTnT/cTnI)Also part of AL amyloidosis staging
24-hour urine proteinQuantifies proteinuria
Serum creatinine / eGFRRenal function assessment
SAA levelElevated in AA amyloidosis; useful for monitoring treatment response
Radiolabeled SAP scintigraphy (123I-SAP)Non-invasive whole-body scan to map amyloid burden and distribution; SAP component binds all amyloid deposits - available mainly in UK
99mTc-DPD/PYP/HMDP scintigraphy (bone scan)Highly specific for ATTR cardiac amyloidosis (grade 2-3 uptake in heart); non-invasive; can diagnose ATTRwt without biopsy when combined with absence of monoclonal protein
Serum transthyretin (TTR) levelLow in hereditary ATTR
Nerve conduction studies / EMGDocuments peripheral neuropathy pattern
- Brenner and Rector's The Kidney; Robbins, Cotran & Kumar Pathologic Basis of Disease; Tietz Textbook of Laboratory Medicine

Diagnosis Summary Algorithm

Clinical suspicion
        ↓
Screen: SPEP, IFE, serum FLC, 24h urine IFE
        ↓
Tissue biopsy (fat pad → rectal → organ)
        ↓
Congo red stain → apple-green birefringence?
        ↓ YES
Typing: IHC or LMD-mass spectrometry
        ↓
AL?          AA?           ATTR?
→ FLC, BM   → SAA, CRP   → Genetic test
   biopsy     inflam.        echocardiogram
              workup         DPD scan

Prognosis (Brief)

  • AL amyloidosis: Median survival ~2 years without treatment; poorer if myeloma-associated. Newer plasma cell-targeted therapies (bortezomib, daratumumab-based regimens) have significantly improved outcomes
  • AA amyloidosis: Depends on control of the underlying inflammatory disease; renal function can stabilize or improve with anti-inflammatory therapy
  • ATTRv amyloidosis: Liver transplant (removes source of mutant TTR); tafamidis (TTR stabilizer) and RNA-interference agents (patisiran, inotersen) have shown efficacy in randomized trials
  • ATTRwt amyloidosis: Tafamidis approved and significantly reduces mortality in cardiac ATTR
Recent Evidence: A 2025 systematic review [PMID: 39819351] on ATTR amyloidosis epidemiology confirms the increasing prevalence of ATTRwt with population aging, and highlights that the disease remains under-diagnosed. No recent meta-analyses contradict the established diagnostic approach above.
This is a shared conversation. Sign in to Orris to start your own chat.